Kempen JH - Search Results

1

Validation of the Online Collaborative Ocular Tuberculosis Study Calculator for Tubercular Uveitis.

Zhang L, Rojas-Carabali W, Choo SS, Thng ZX, Lim YH, Lee B, Jun SW, Patnaik G, Biswas J, Agarwal A, Testi I, Mahajan S, Kempen JH, Smith JR, McCluskey P, Kon OM, Nguyen QD, Pavesio C, Gupta V, Agrawal R; Collaborative Ocular Tuberculosis Study (COTS) Group. Zhang L, et al. Among authors: kempen jh. JAMA Ophthalmol. 2024 Dec 1;142(12):1140-1148. doi: 10.1001/jamaophthalmol.2024.4567. JAMA Ophthalmol. 2024. PMID: 39480402

2

Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.

Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Nguyen QD, et al. Among authors: kempen jh. Am J Ophthalmol. 2000 May;129(5):634-9. doi: 10.1016/s0002-9394(00)00356-1. Am J Ophthalmol. 2000. PMID: 10844056 Free article.

3

Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.

Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Kempen JH, et al. Arch Ophthalmol. 2001 Jan;119(1):33-40. Arch Ophthalmol. 2001. PMID: 11146724

4

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Jabs DA, et al. Among authors: kempen jh. Am J Ophthalmol. 2002 Jan;133(1):48-61. doi: 10.1016/s0002-9394(01)01322-8. Am J Ophthalmol. 2002. PMID: 11755839

5

Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS.

Kempen JH, Frick KD, Jabs DA. Kempen JH, et al. Pharmacoeconomics. 2001;19(12):1199-208. doi: 10.2165/00019053-200119120-00002. Pharmacoeconomics. 2001. PMID: 11772155

6

Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.

Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV; Cytomegalovirus Retinitis and Viral Resistance Study Group. Jabs DA, et al. Among authors: kempen jh. Am J Ophthalmol. 2003 Jan;135(1):26-34. doi: 10.1016/s0002-9394(02)01759-2. Am J Ophthalmol. 2003. PMID: 12504693 Clinical Trial.

7

Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome.

Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Kempen JH, et al. Arch Ophthalmol. 2003 Apr;121(4):466-76. doi: 10.1001/archopht.121.4.466. Arch Ophthalmol. 2003. PMID: 12695243

8

The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.

Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA; Studies of Ocular Complications of AIDS Researh Group. Kempen JH, et al. Ophthalmology. 2003 May;110(5):987-95. doi: 10.1016/S0161-6420(03)00089-7. Ophthalmology. 2003. PMID: 12750102

9

Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis.

Tanna AP, Kempen JH, Dunn JP, Haller JA, Jabs DA. Tanna AP, et al. Among authors: kempen jh. Am J Ophthalmol. 2003 Dec;136(6):1009-15. doi: 10.1016/s0002-9394(03)00724-4. Am J Ophthalmol. 2003. PMID: 14644210

10

Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression.

Hubbard LD, Ricks MO, Martin BK, Bressler NM, Kempen JH, Dunn JP, Jabs DA; Cytomegalovirus Retinitis and Viral Resistance Study Group. Hubbard LD, et al. Among authors: kempen jh. Am J Ophthalmol. 2004 Mar;137(3):426-34. doi: 10.1016/j.ajo.2003.10.002. Am J Ophthalmol. 2004. PMID: 15013864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters